FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

Compounding pharmacies can continue cashing in on the GLP-1 gold rush — for now. But the FDA could once again pull their products from the market. It all comes down to whether or not the agency keeps branded GLP-1 medicines on its shortage list.